| pubmed-article:19901115 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:19901115 | lifeskim:mentions | umls-concept:C1140680 | lld:lifeskim |
| pubmed-article:19901115 | lifeskim:mentions | umls-concept:C0238122 | lld:lifeskim |
| pubmed-article:19901115 | lifeskim:mentions | umls-concept:C0153467 | lld:lifeskim |
| pubmed-article:19901115 | lifeskim:mentions | umls-concept:C0441655 | lld:lifeskim |
| pubmed-article:19901115 | lifeskim:mentions | umls-concept:C0045093 | lld:lifeskim |
| pubmed-article:19901115 | lifeskim:mentions | umls-concept:C1328025 | lld:lifeskim |
| pubmed-article:19901115 | lifeskim:mentions | umls-concept:C0205210 | lld:lifeskim |
| pubmed-article:19901115 | lifeskim:mentions | umls-concept:C0205225 | lld:lifeskim |
| pubmed-article:19901115 | pubmed:issue | 7 | lld:pubmed |
| pubmed-article:19901115 | pubmed:dateCreated | 2010-2-25 | lld:pubmed |
| pubmed-article:19901115 | pubmed:abstractText | Pertuzumab is a humanized monoclonal antibody that inhibits human epidermal growth factor receptor 2 (HER2) heterodimerization and has single-agent activity in recurrent epithelial ovarian cancer. The primary objective of this phase II study was to characterize the safety and estimate progression-free survival (PFS) of pertuzumab with gemcitabine in patients with platinum-resistant ovarian cancer. | lld:pubmed |
| pubmed-article:19901115 | pubmed:language | eng | lld:pubmed |
| pubmed-article:19901115 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19901115 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:19901115 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19901115 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19901115 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19901115 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19901115 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19901115 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19901115 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19901115 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19901115 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19901115 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:19901115 | pubmed:month | Mar | lld:pubmed |
| pubmed-article:19901115 | pubmed:issn | 1527-7755 | lld:pubmed |
| pubmed-article:19901115 | pubmed:author | pubmed-author:DizonDon SDS | lld:pubmed |
| pubmed-article:19901115 | pubmed:author | pubmed-author:GoldMichael... | lld:pubmed |
| pubmed-article:19901115 | pubmed:author | pubmed-author:PatonVirginia... | lld:pubmed |
| pubmed-article:19901115 | pubmed:author | pubmed-author:LinChin-YuCY | lld:pubmed |
| pubmed-article:19901115 | pubmed:author | pubmed-author:MatulonisUrsu... | lld:pubmed |
| pubmed-article:19901115 | pubmed:author | pubmed-author:SliwkowskiMar... | lld:pubmed |
| pubmed-article:19901115 | pubmed:author | pubmed-author:UelandFrederi... | lld:pubmed |
| pubmed-article:19901115 | pubmed:author | pubmed-author:KelseyStephen... | lld:pubmed |
| pubmed-article:19901115 | pubmed:author | pubmed-author:NgKimmieK | lld:pubmed |
| pubmed-article:19901115 | pubmed:author | pubmed-author:MakhijaSharmi... | lld:pubmed |
| pubmed-article:19901115 | pubmed:author | pubmed-author:StraussAndrea... | lld:pubmed |
| pubmed-article:19901115 | pubmed:author | pubmed-author:AmlerLukas... | lld:pubmed |
| pubmed-article:19901115 | pubmed:author | pubmed-author:JanuarioThoma... | lld:pubmed |
| pubmed-article:19901115 | pubmed:author | pubmed-author:GlennDanaD | lld:pubmed |
| pubmed-article:19901115 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:19901115 | pubmed:day | 1 | lld:pubmed |
| pubmed-article:19901115 | pubmed:volume | 28 | lld:pubmed |
| pubmed-article:19901115 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:19901115 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:19901115 | pubmed:pagination | 1215-23 | lld:pubmed |
| pubmed-article:19901115 | pubmed:dateRevised | 2011-11-17 | lld:pubmed |
| pubmed-article:19901115 | pubmed:meshHeading | pubmed-meshheading:19901115... | lld:pubmed |
| pubmed-article:19901115 | pubmed:meshHeading | pubmed-meshheading:19901115... | lld:pubmed |
| pubmed-article:19901115 | pubmed:meshHeading | pubmed-meshheading:19901115... | lld:pubmed |
| pubmed-article:19901115 | pubmed:meshHeading | pubmed-meshheading:19901115... | lld:pubmed |
| pubmed-article:19901115 | pubmed:meshHeading | pubmed-meshheading:19901115... | lld:pubmed |
| pubmed-article:19901115 | pubmed:meshHeading | pubmed-meshheading:19901115... | lld:pubmed |
| pubmed-article:19901115 | pubmed:meshHeading | pubmed-meshheading:19901115... | lld:pubmed |
| pubmed-article:19901115 | pubmed:meshHeading | pubmed-meshheading:19901115... | lld:pubmed |
| pubmed-article:19901115 | pubmed:meshHeading | pubmed-meshheading:19901115... | lld:pubmed |
| pubmed-article:19901115 | pubmed:meshHeading | pubmed-meshheading:19901115... | lld:pubmed |
| pubmed-article:19901115 | pubmed:meshHeading | pubmed-meshheading:19901115... | lld:pubmed |
| pubmed-article:19901115 | pubmed:meshHeading | pubmed-meshheading:19901115... | lld:pubmed |
| pubmed-article:19901115 | pubmed:meshHeading | pubmed-meshheading:19901115... | lld:pubmed |
| pubmed-article:19901115 | pubmed:meshHeading | pubmed-meshheading:19901115... | lld:pubmed |
| pubmed-article:19901115 | pubmed:year | 2010 | lld:pubmed |
| pubmed-article:19901115 | pubmed:articleTitle | Clinical activity of gemcitabine plus pertuzumab in platinum-resistant ovarian cancer, fallopian tube cancer, or primary peritoneal cancer. | lld:pubmed |
| pubmed-article:19901115 | pubmed:affiliation | Department of Gynecology and Obstetrics, Emory University School of Medicine, Woodruff Memorial Research Bldg, 1639 Pierce Dr 4305, Atlanta, GA 30322, USA. drmakhija@yahoo.com | lld:pubmed |
| pubmed-article:19901115 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:19901115 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:19901115 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:19901115 | pubmed:publicationType | Multicenter Study | lld:pubmed |
| pubmed-article:19901115 | pubmed:publicationType | Clinical Trial, Phase II | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19901115 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19901115 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19901115 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19901115 | lld:pubmed |
